| Drug Type Fusion protein | 
| Synonyms BMD 1221 | 
| Target | 
| Action modulators | 
| Mechanism PTH1R modulators(Parathyroid hormone receptor modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseClinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Fractures, Bone | Clinical | - | - | 






